- Fourth quarter revenues of $1.84 billion, down 1.4% versus 2017
- Fourth quarter diluted EPS of $0.92 on a reported basis, down 49.5% from 2017 which included a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.36 on an adjusted basis excluding amortization, down 2.9% from 2017
- Full year revenues of $7.53 billion, up 1.7% from 2017
- Full year diluted EPS of $5.29 on a reported basis, down 3.8% from 2017; and $6.31 on an adjusted basis excluding amortizati...
Transaction expands access to diagnostic innovations in clinical and pathology services for patients, physicians and hospitals throughout Missouri and surrounding Midwestern states
SECAUCUS, N.J. and COLUMBIA, Mo., Feb. 11, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Labor...
SECAUCUS, N.J., Jan. 22, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year.
The annual survey designated Quest Diagnostics as one of only five companies to attain Most Admired status in the "Health Care: Pharmacy and Other Services" industry category.
"We are h...
Nearly Six in Ten Recognize Access to Health Vitals is Important in an Emergency, Yet Nearly 30 Percent Keep Lab Results in a File Cabinet at Home
Challenges Retaining and Accessing Key Medical Information are Key Drivers to This Lack of Knowledge
SECAUCUS, N.J., Jan. 14, 2019 /PRNewswire/ -- Americans have multiple numbers at their fingertips, but some of the numbers that could be most important to their health are not among them. New research released today by Quest Diagnostics (NYSE: DG...
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.